Literature DB >> 18081624

Cognitive insight and acute psychosis in schizophrenia.

Emre Bora1, Arzu Erkan, Bulent Kayahan, Baybars Veznedaroglu.   

Abstract

Cognitive insight is a new concept. There are very few data regarding the relationship between cognitive insight and positive symptoms. The goal of the present study was to investigate the impact of acute psychosis (delusions and hallucinations) on overconfidence in judgments and self-reflectiveness of patients with schizophrenia. The Beck Cognitive Insight Scale was used to compare the cognitive insight of schizophrenia patients with (n = 93) and without (n = 45) current psychotic symptoms. Clinical symptoms and clinical insight of the patients were also assessed. The present findings suggest that both overconfidence in judgments and impaired self-reflectiveness are associated with acute psychosis. Only diminished self-reflectiveness seem to be improved following hospitalization. Although overconfidence of schizophrenia patients in their judgments was more severe in schizophrenia patients with psychotic symptoms, self-certainty of schizophrenia patients may be a relatively persistent characteristic that is also present after recovery of psychosis. Studies with larger samples involving follow up for longer periods will be valuable to understand the nature of the relationship between cognitive insight and clinical symptoms of schizophrenia.

Entities:  

Mesh:

Year:  2007        PMID: 18081624     DOI: 10.1111/j.1440-1819.2007.01731.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  19 in total

Review 1.  Assessment of cognitive insight: a qualitative review.

Authors:  Sally E Riggs; Paul M Grant; Dimitri Perivoliotis; Aaron T Beck
Journal:  Schizophr Bull       Date:  2010-08-06       Impact factor: 9.306

2.  Clinical and Cognitive Insight in a Compensatory Cognitive Training Intervention.

Authors:  Cynthia Z Burton; Lea Vella; Elizabeth W Twamley
Journal:  Am J Psychiatr Rehabil       Date:  2011-10-01

3.  The Beck Cognitive Insight Scale (BCIS): translation and validation of the Taiwanese version.

Authors:  Yu-Chen Kao; Yia-Ping Liu
Journal:  BMC Psychiatry       Date:  2010-04-09       Impact factor: 3.630

4.  Cognitive insight and objective quality of life in people with schizophrenia and auditory hallucinations.

Authors:  Ruchika Rathee; Tanya M Luhrmann; Triptish Bhatia; Smita N Deshpande
Journal:  Psychiatry Res       Date:  2017-09-13       Impact factor: 3.222

5.  Domains of awareness in schizophrenia.

Authors:  J Gilleen; K Greenwood; A S David
Journal:  Schizophr Bull       Date:  2010-09-17       Impact factor: 9.306

6.  Failures of metacognition and lack of insight in neuropsychiatric disorders.

Authors:  Anthony S David; Nicholas Bedford; Ben Wiffen; James Gilleen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-05-19       Impact factor: 6.237

7.  Cognitive insight in individuals at clinical high risk for psychosis.

Authors:  David Kimhy; Lauren Jobson-Ahmed; Shelly Ben-David; Lisa Ramadhar; Dolores Malaspina; Cheryl M Corcoran
Journal:  Early Interv Psychiatry       Date:  2013-01-24       Impact factor: 2.732

8.  Neurocognitive insight and objective cognitive functioning in schizophrenia.

Authors:  Cynthia Z Burton; Philip D Harvey; Thomas L Patterson; Elizabeth W Twamley
Journal:  Schizophr Res       Date:  2016-01-23       Impact factor: 4.939

9.  The structural neuroanatomy of metacognitive insight in schizophrenia and its psychopathological and neuropsychological correlates.

Authors:  Gianfranco Spalletta; Fabrizio Piras; Federica Piras; Carlo Caltagirone; Maria Donata Orfei
Journal:  Hum Brain Mapp       Date:  2014-04-03       Impact factor: 5.038

10.  Insight in schizophrenia: involvement of self-reflection networks?

Authors:  Lisette van der Meer; Annerieke E de Vos; Annemarie P M Stiekema; Gerdina H M Pijnenborg; Marie-José van Tol; Willem A Nolen; Anthony S David; André Aleman
Journal:  Schizophr Bull       Date:  2012-10-27       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.